EMBL Raises 10M Euros for New Technology Fund | GenomeWeb

NEW YORK, Dec. 10 – The European Molecular Biology Laboratory has raised 10 million euros ($8.9 million) for its first technology fund, which will look to invest in start up companies emerging from the research center. 

The European Molecular Biology Laboratory Enterprise Management fund, or EMBLEM, received funds from investors including  3i of the UK, BankInvest of Denmark, and Marco Polo of Spain. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.